{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:33:04Z","timestamp":1790321584079,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1124\/jpet.120.265843","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T17:35:22Z","timestamp":1596648922000},"page":"115-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Oral Pretreatment with Galantamine Effectively Mitigates the Acute Toxicity of a Supralethal Dose of Soman in Cynomolgus Monkeys Posttreated with Conventional Antidotes"],"prefix":"10.1016","volume":"375","author":[{"given":"Malcolm","family":"Lane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u2019Arice","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D.","family":"Pescrille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasco","family":"Aracava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William P.","family":"Fawcett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. William","family":"Basinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edna F.R.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edson X.","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.120.265843_bib1","unstructured":"Adams NL (1990) The intramuscular lethality of soman (GD) in the cynomolgus monkey. USAMRICD-TR-90-06 US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD. ADA224887. NLM unique ID 9108742."},{"key":"10.1124\/jpet.120.265843_bib2","doi-asserted-by":"crossref","first-page":"507571","DOI":"10.1155\/2012\/507571","article-title":"FDA experience with medical countermeasures under the animal rule","volume":"2012","author":"Aebersold","year":"2012","journal-title":"Adv Prev Med"},{"key":"10.1124\/jpet.120.265843_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1152\/physrev.00015.2008","article-title":"Mammalian nicotinic acetylcholine receptors: from structure to function","volume":"89","author":"Albuquerque","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1124\/jpet.120.265843_bib4","doi-asserted-by":"crossref","first-page":"13220","DOI":"10.1073\/pnas.0605370103","article-title":"Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents","volume":"103","author":"Albuquerque","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.120.265843_bib5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/01480549209014158","article-title":"The effect of pyridostigmine pretreatment on oxime efficacy against intoxication by soman or VX in rats","volume":"15","author":"Anderson","year":"1992","journal-title":"Drug Chem Toxicol"},{"key":"10.1124\/jpet.120.265843_bib6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neuro.2010.05.014","article-title":"Higher susceptibility of the ventral versus the dorsal hippocampus and the posteroventral versus anterodorsal amygdala to soman-induced neuropathology","volume":"31","author":"Apland","year":"2010","journal-title":"Neurotoxicology"},{"key":"10.1124\/jpet.120.265843_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/jat.2550130306","article-title":"Soman-induced morphological changes: an overview in the non-human primate","volume":"13","author":"Baze","year":"1993","journal-title":"J Appl Toxicol"},{"key":"10.1124\/jpet.120.265843_bib8","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.trci.2019.09.011","article-title":"Comparison of cholinesterase inhibitor safety in real-world practice","volume":"5","author":"Carney","year":"2019","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1124\/jpet.120.265843_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/24734306.2017.1373503","article-title":"Toxic chemical weapons of assassination and warfare: nerve agents VX and sarin","volume":"1","author":"Chai","year":"2017","journal-title":"Toxicol Commun"},{"key":"10.1124\/jpet.120.265843_bib10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neulet.2006.01.029","article-title":"Early reduction of NeuN antigenicity induced by soman poisoning in mice can be used to predict delayed neuronal degeneration in the hippocampus","volume":"398","author":"Collombet","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1124\/jpet.120.265843_bib11","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.1523\/JNEUROSCI.18-15-05663.1998","article-title":"Experimental brain injury induces regionally distinct apoptosis during the acute and delayed post-traumatic period","volume":"18","author":"Conti","year":"1998","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.120.265843_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.2042-7158.1979.tb13504.x","article-title":"The protection of primates against soman poisoning by pretreatment with pyridostigmine","volume":"31","author":"Dirnhuber","year":"1979","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/jpet.120.265843_bib13","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/jama.1989.03430050065028","article-title":"Progress in medical defense against nerve agents","volume":"262","author":"Dunn","year":"1989","journal-title":"JAMA"},{"key":"10.1124\/jpet.120.265843_bib14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.bcp.2006.04.015","article-title":"Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds","volume":"72","author":"Eckert","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.120.265843_bib15","doi-asserted-by":"crossref","first-page":"E1222","DOI":"10.3390\/ijms20051222","article-title":"Novichoks: the dangerous fourth generation of chemical weapons","volume":"20","author":"Franca","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1124\/jpet.120.265843_bib16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.vascn.2008.05.002","article-title":"A functional observational battery in non-human primates for regulatory-required neurobehavioral assessments","volume":"58","author":"Gauvin","year":"2008","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1124\/jpet.120.265843_bib17","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s12640-017-9815-9","article-title":"Neuroprotective effects of galantamine on nerve agent-induced neuroglial and biochemical changes","volume":"33","author":"Golime","year":"2018","journal-title":"Neurotox Res"},{"key":"10.1124\/jpet.120.265843_bib18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0041-008X(78)80045-3","article-title":"The protection of animals against organophosphate poisoning by pretreatment with a carbamate","volume":"43","author":"Gordon","year":"1978","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.120.265843_bib19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cbi.2005.10.064","article-title":"Inhibition of guinea pig hemi-diaphragm acetylcholinesterase activity by pyridostigmine bromide and protection against soman toxicity","volume":"157\u2013158","author":"Haigh","year":"2005","journal-title":"Chem Biol Interact"},{"key":"10.1124\/jpet.120.265843_bib20","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1007\/s11064-016-2120-9","article-title":"Time course, behavioral safety, and protective efficacy of centrally active reversible acetylcholinesterase inhibitors in Cynomolgus macaques","volume":"42","author":"Hamilton","year":"2017","journal-title":"Neurochem Res"},{"key":"10.1124\/jpet.120.265843_bib21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0022-510X(90)90185-P","article-title":"Decreased brain pathology in organophosphate-exposed rhesus monkeys following benzodiazepine therapy","volume":"98","author":"Hayward","year":"1990","journal-title":"J Neurol Sci"},{"key":"10.1124\/jpet.120.265843_bib22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3109\/01480548009002226","article-title":"Effects of carbamates on whole blood cholinesterase activity: chemical protection against soman","volume":"3","author":"Heyl","year":"1980","journal-title":"Drug Chem Toxicol"},{"key":"10.1124\/jpet.120.265843_bib23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.taap.2009.07.029","article-title":"Galantamine is a novel post-exposure therapeutic against lethal VX challenge","volume":"240","author":"Hilmas","year":"2009","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.120.265843_bib24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/157488410791110805","article-title":"A review of clinical pharmacokinetics and pharmacodynamics of galantamine, a reversible acetylcholinesterase inhibitor for the treatment of Alzheimer\u2019s disease, in healthy subjects and patients","volume":"5","author":"Huang","year":"2010","journal-title":"Curr Clin Pharmacol"},{"key":"10.1124\/jpet.120.265843_bib25","series-title":"Harrison\u2019s Principles of Internal Medicine","first-page":"1779","article-title":"Chemical terrorism: introduction","author":"Hurst","year":"2012"},{"key":"10.1124\/jpet.120.265843_bib26","article-title":"Civilian research on chemical medical countermeasures","author":"Jett","year":"2019","journal-title":"Toxicol Mech Methods"},{"key":"10.1124\/jpet.120.265843_bib27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0003-2697(75)90423-6","article-title":"A rapid, simple radiometric assay for cholinesterase, suitable for multiple determinations","volume":"64","author":"Johnson","year":"1975","journal-title":"Anal Biochem"},{"key":"10.1124\/jpet.120.265843_bib28","unstructured":"Joiner R Kluwe W (1988) Multiple animal studies for medical chemical defense program in soldier\/patient decontamination and drug development. Task 85-18: Conduct of Pralidoxime chloride, atropine in citrate buffer and pyridostigmine bromide pharmacokinetic studies, and comparative evaluation of the efficacy of pyridostigmine plus atropine. pp 67-73. Available from the National Technical Information Service (https:\/\/ntrl.ntis.gov\/NTRL\/), accession number ADB127309."},{"key":"10.1124\/jpet.120.265843_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1527-3458.2002.tb00221.x","article-title":"Galantamine--a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer\u2019s disease","volume":"8","author":"Lilienfeld","year":"2002","journal-title":"CNS Drug Rev"},{"key":"10.1124\/jpet.120.265843_bib30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/jat.3662","article-title":"Reversible cholinesterase inhibitors as pretreatment for exposure to organophosphates. A review","volume":"39","author":"Lorke","year":"2019","journal-title":"J Appl Toxicol"},{"key":"10.1124\/jpet.120.265843_bib31","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuro.2011.07.001","article-title":"Galantamine counteracts development of learning impairment in guinea pigs exposed to the organophosphorus poison soman: clinical significance","volume":"32","author":"Mamczarz","year":"2011","journal-title":"Neurotoxicology"},{"key":"10.1124\/jpet.120.265843_bib32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/00139709-200625040-00009","article-title":"The role of oximes in the treatment of nerve agent poisoning in civilian casualties","volume":"25","author":"Marrs","year":"2006","journal-title":"Toxicol Rev"},{"key":"10.1124\/jpet.120.265843_bib33","series-title":"Midazolam: an improved anticonvulsant treatment for nerve agent-induced seizures","author":"McDonough","year":"2002"},{"key":"10.1124\/jpet.120.265843_bib34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/01480540903483417","article-title":"Time-dependent reduction in the anticonvulsant effectiveness of diazepam against soman-induced seizures in Guinea pigs","volume":"33","author":"McDonough","year":"2010","journal-title":"Drug Chem Toxicol"},{"key":"10.1124\/jpet.120.265843_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.physbeh.2014.09.010","article-title":"Physiological and neurobehavioral effects of cholinesterase inhibition in healthy adults","volume":"138","author":"Morasch","year":"2015","journal-title":"Physiol Behav"},{"key":"10.1124\/jpet.120.265843_bib36","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1006\/taap.1997.8287","article-title":"Comparison of the in vitro sensitivity of rat acetylcholinesterase to chlorpyrifos-oxon: what do tissue IC50 values represent?","volume":"148","author":"Mortensen","year":"1998","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.120.265843_bib37","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.neubiorev.2016.10.017","article-title":"Pretreatment and prophylaxis against nerve agent poisoning: are undesirable behavioral side effects unavoidable?","volume":"71","author":"Myhrer","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/jpet.120.265843_bib38","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.pbb.2010.02.010","article-title":"Behavioral side effects in rats treated with acetylcholinesterase inhibitors suggested used as prophylactics against nerve agents","volume":"95","author":"Myhrer","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.120.265843_bib39","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1212\/CPJ.0000000000000641","article-title":"Therapy for acute nerve agent poisoning: an update","volume":"9","author":"Newmark","year":"2019","journal-title":"Neurol Clin Pract"},{"key":"10.1124\/jpet.120.265843_bib40","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1289\/ehp.011091169","article-title":"Effects of sarin on the nervous system in rescue team staff members and police officers 3 years after the Tokyo subway sarin attack","volume":"109","author":"Nishiwaki","year":"2001","journal-title":"Environ Health Perspect"},{"key":"10.1124\/jpet.120.265843_bib41","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/0192623311436180","article-title":"Technical guide for nervous system sampling of the cynomolgus monkey for general toxicity studies","volume":"40","author":"Pardo","year":"2012","journal-title":"Toxicol Pathol"},{"key":"10.1124\/jpet.120.265843_bib42","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s12031-009-9234-3","article-title":"Molecular and cellular actions of galantamine: clinical implications for treatment of organophosphorus poisoning","volume":"40","author":"Pereira","year":"2010","journal-title":"J Mol Neurosci"},{"key":"10.1124\/jpet.120.265843_bib43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pbb.2013.01.015","article-title":"Tremorolytic effects of safinamide in animal models of drug-induced parkinsonian tremor","volume":"105","author":"Podurgiel","year":"2013","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.120.265843_bib44","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J"},{"key":"10.1124\/jpet.120.265843_bib45","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00228-001-0405-6","article-title":"Estimating the starting dose for entry into humans: principles and practice","volume":"57","author":"Reigner","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/jpet.120.265843_bib46","first-page":"225","article-title":"Central respiratory effects versus neuromuscular actions of nerve agents","volume":"7","author":"Rickett","year":"1986","journal-title":"Neurotoxicology"},{"key":"10.1124\/jpet.120.265843_bib47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/milmed\/166.suppl_2.21","article-title":"Psychological casualties resulting from chemical and biological weapons","volume":"166","author":"Romano","year":"2001","journal-title":"Mil Med"},{"key":"10.1124\/jpet.120.265843_bib48","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0006-8993(00)02513-0","article-title":"Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration","volume":"874","author":"Schmued","year":"2000","journal-title":"Brain Res"},{"key":"10.1124\/jpet.120.265843_bib49","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4172\/2155-9872.1000144","article-title":"An extraction assay analysis for galanthamine in guinea pig plasma and its Application to nerve agent countermeasures","volume":"3","author":"Steiner","year":"2012","journal-title":"J Anal Bioanal Tech"},{"key":"10.1124\/jpet.120.265843_bib50","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/bmc.3191","article-title":"Highly sensitive LC-MS\/MS method for determination of galantamine in rat plasma: application to pharmacokinetic studies in rats","volume":"28","author":"Suresh","year":"2014","journal-title":"Biomed Chromatogr"},{"key":"10.1124\/jpet.120.265843_bib51","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0091-3057(89)90364-X","article-title":"Galanthamine, an acetylcholinesterase inhibitor: a time course of the effects on performance and neurochemical parameters in mice","volume":"34","author":"Sweeney","year":"1989","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.120.265843_bib52","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0006-2952(91)90022-W","article-title":"In vitro effects of various cholinesterase inhibitors on acetyl- and butyryl-cholinesterases of healthy volunteers","volume":"41","author":"Thomsen","year":"1991","journal-title":"Biochemical Pharmacol"},{"key":"10.1124\/jpet.120.265843_bib53","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0272-0590(91)90183-5","article-title":"Effectiveness of oral pyridostigmine pretreatment and cholinolytic-oxime therapy against soman intoxication in nonhuman primates","volume":"17","author":"von Bredow","year":"1991","journal-title":"Fundam Appl Toxicol"},{"key":"10.1124\/jpet.120.265843_bib54","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1177\/009127000204200907","article-title":"Galantamine pharmacokinetics, safety, and tolerability profiles are similar in healthy Caucasian and Japanese subjects","volume":"42","author":"Zhao","year":"2002","journal-title":"J Clin Pharmacol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524270166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524270166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.120.265843","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T06:35:46Z","timestamp":1739946946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524270166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0022356524270166"],"URL":"https:\/\/doi.org\/10.1124\/jpet.120.265843","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.02.03.932798","asserted-by":"object"}]},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral Pretreatment with Galantamine Effectively Mitigates the Acute Toxicity of a Supralethal Dose of Soman in Cynomolgus Monkeys Posttreated with Conventional Antidotes","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.120.265843","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}